Abstract:
Diabetes mellitus is a leading non-communicable disease worldwide,
and its management remains a major healthcare challenge. Gymnema sylvestre
(Sirukurinjan) is a well-known antidiabetic plant in traditional medicine. In recent
years, glycoproteins have attained considerable attention as potent antidiabetic
agents, but no studies have been reported on the antidiabetic activity of glycoproteins
from G. sylvestre.
Objective: To evaluate the α-amylase inhibitory activity of partially purified
glycoproteins extracted from G. sylvestre.
Methodology: Partially purified glycoproteins were extracted from G. sylvestre
leaves using ammonium sulfate precipitation followed by dialysis. Total sugar
content was measured, and structural characterisation was performed using FT-IR
analysis. The α-amylase inhibitory activity of glycoprotein was evaluated using the
DNSA assay with acarbose as a standard. Statistically, IC50 of standard and
glycoproteins were analysed using one-way ANOVA followed by Tukey’s test, with
significance set at p < 0.05.
Results: The G. sylvestre extraction yielded 0.97% partially purified glycoproteins
with a sugar content of 158.67 µg/mL. FTIR analysis confirmed the presence of
characteristic O–H stretching and prominent amide bands. In α-amylase inhibition
assays, acarbose exhibited the strongest effect (IC₅₀: 42.10 ± 2.97 µg/mL), while G.
sylvestre partially purified glycoproteins demonstrated moderate activity (IC₅₀:
388.45 ± 0.81 µg/mL), with a significant difference between them. (p < 0.05).
Conclusion: This study highlights that partially purified glycoproteins from G.
sylvestre possess measurable α-amylase inhibitory activity, supporting their potential
role in diabetes management. Further structural characterisation, following the
completion of purification of glycoproteins and in vivo validation, is needed.
